Get updates on COVID-19 research at COVID-19 Resource
Crop Biotech Update

Golden Rice Gets Approval from US FDA

May 30, 2018

On May 24, 2018, the United States Food and Drug Administration (US FDA) released a statement on GR2E Golden Rice, a rice genetically engineered to produce provitamin A carotenoids. The US FDA statement concurs with the assessment of the International Rice Research Institute (IRRI) regarding the safety and nutrition of Golden Rice.

The US FDA approval is the third positive food safety evaluation of Golden Rice, after the approvals granted by Food Standards Australia New Zealand (FSANZ) and Health Canada in February and March 2018, respectively.

"Each regulatory application that Golden Rice completes with national regulatory agencies takes us one step closer to bringing Golden Rice to the people who need it the most," says IRRI Director General Matthew Morell. He added that the rigorous safety standards observed by the US FDA and other agencies provide a model for decision-making in all countries wishing to reap the benefits of Golden Rice.

For more details, read the IRRI media release.